Japanese Gas Utilities Stock News

Latest Earnings Snapshot and What Stood Out Nireco (TSE:6863) has reported its Q3 2026 numbers with recent quarterly revenue sitting at ¥2,768 million and Basic EPS at ¥53.54, setting a clear benchmark for how the rest of the year is shaping up. The company has seen revenue move from ¥2,519 million in Q2 2025 to ¥2,662 million in Q3 2025 and then to ¥2,768 million in Q2 2026, while Basic EPS shifted from ¥46.47 to ¥62.45 and then to ¥53.54 over the same quarters, giving you a sense of how the...

Iseki (TSE:6310) has just posted its FY 2025 numbers, with third quarter revenue at ¥42,844 million and basic EPS of ¥37.56. Trailing twelve month figures show revenue of ¥183,558 million and basic EPS of ¥72.09 as the business continues to build on its recent return to profitability. Over recent periods, the company has seen revenue move from ¥168,425 million to ¥183,558 million on a trailing basis, with EPS shifting from a loss of ¥133.59 to a profit of ¥72.09, giving investors a clearer...

GreensLtd (TSE:6547) sets the stage with recent earnings GreensLtd (TSE:6547) has followed up its recent results with a trailing twelve month snapshot that shows total revenue of ¥51.2b and basic EPS of ¥369.15, against year-on-year earnings growth of 8.7% and revenue growth of 5.5%. Over the past reported periods, revenue has moved from ¥10.4b in Q4 2024 to ¥11.0b in Q3 2025 and then ¥13.5b in Q1 2026. Quarterly basic EPS shifted from ¥32.16 to ¥20.77, then to ¥71.60 and ¥113.48 across the...

If you are trying to figure out whether DIC is still reasonably priced or already reflecting a lot of optimism, you will want to look closely at what its current valuation is really telling you. The share price sits at ¥4,250, with returns of 7.1% over the last week, 12.8% over the last month, 17.1% year to date, 35.4% over 1 year, 101.6% over 3 years and 83.4% over 5 years. This puts recent and longer term moves front and center in any assessment of risk and reward. Recent news around DIC...

Loadstar Capital K.K (TSE:3482) has laid out its FY 2025 scorecard with third quarter revenue of ¥8.1b and basic EPS of ¥45.00. This is set against a trailing twelve month backdrop where revenue ranges from ¥29.2b to ¥39.0b and EPS moves between ¥385.45 and ¥536.89. Across recent quarters, the company has seen revenue fluctuate between ¥7.0b and ¥11.1b while basic EPS has shifted from ¥45.00 to ¥216.43. This gives investors a clearer view of how the top line and per-share results are tracking...

Why Toray’s latest moves matter for shareholders Toray Industries (TSE:3402) has been in focus after joining a 14 company supply chain for renewable plastics tied to Sony products, alongside fresh nine month earnings and updated full year guidance. For you as a shareholder or potential investor, these three developments line up in an interesting way. You have a new role for Toray in a global materials project, a snapshot of recent profitability, and management’s current view of the year ahead...

Hodogaya Chemical (TSE:4112) has put its latest numbers on the table, with Q2 2026 revenue at ¥11.2b and basic EPS of ¥38.92, alongside net income of ¥619m. This gives investors fresh data on how the business is running ahead of its Q3 2026 update. The company has seen revenue move between ¥10.6b and ¥14.5b over the last six reported quarters, while basic EPS ranged from ¥18.56 to ¥107.52. This outlines a wide band of earnings outcomes that frames how you might read the latest print and what...

OVAL (TSE:7727) has put fresh numbers on the table for Q3 2026, with Q2 2026 revenue at ¥3,704 million and basic EPS of ¥11.19, alongside trailing 12 month EPS growth of 23.9% and a 5 year annualised earnings growth rate of 40.7%. The company has seen revenue move from ¥3,299 million in Q1 2025 to ¥3,829 million in Q2 2025, then to ¥3,574 million in Q3 2025 and ¥4,346 million in Q4 2025. Over the same period, quarterly basic EPS ranged between ¥6.25 and ¥15.71, setting up a picture where...

Kuriyama Holdings (TSE:3355) has put another quarter on the books, with FY 2025 Q3 revenue at ¥22.8b and basic EPS of ¥49.67, set against a trailing twelve month EPS of ¥223.83 on revenue of ¥85.1b. The company has seen revenue move from ¥19.0b in FY 2024 Q4 to ¥22.8b in FY 2025 Q3, while quarterly EPS shifted from ¥39.99 to ¥49.67 over the same stretch. This gives investors a clearer view of how recent trading is feeding through to the bottom line. With a trailing net profit margin of 5.2%...

STI Foods HoldingsInc (TSE:2932) has just posted its FY 2025 third quarter numbers, with revenue of ¥10.1b and basic EPS of ¥24.52, while trailing twelve month EPS stands at ¥114.58 on revenue of ¥37.7b. The company has seen revenue move from ¥34.7b to ¥37.7b and trailing EPS shift from ¥109.80 to ¥114.58 over the last reported twelve month periods, giving you a clear read on how the top line and per share earnings have tracked together. With trailing net profit margin edging from 5.6% to...

oRo (TSE:3983) has put fresh numbers on the table for FY 2025, reporting third quarter revenue of ¥2.1 billion and basic EPS of ¥30.64. This is set against a trailing 12 month net profit margin of 23.8% compared with 24.1% in the prior year. The company has seen quarterly revenue move between ¥1.9 billion and ¥2.1 billion over the past few periods, while basic EPS has ranged from ¥21.69 to ¥42.90. This gives investors a clear view of how earnings track alongside that high margin profile. See...

Dainichiseika Color & Chemicals Mfg (TSE:4116) has laid out its latest Q3 2026 scorecard with recent quarterly revenue figures running around ¥30.0b and Basic EPS in the double to triple digit yen range, set against trailing 12 month EPS between roughly ¥351 and ¥656 and revenue between about ¥122.4b and ¥125.1b over the past five reported quarters. The company has seen revenue move in a relatively tight band of roughly ¥30.0b to ¥32.2b per quarter and EPS swing from about ¥8 to almost ¥379...

Takeda Pharmaceutical received FDA priority review for its orexin agonist for narcolepsy type 1, marking an important regulatory milestone for the therapy. The company also announced a multi year AI drug discovery collaboration with Iambic, focused on oncology and gastrointestinal candidates. Both developments arrive as Takeda Pharmaceutical (TSE:4502) trades at ¥5,614.0 per share. Takeda Pharmaceutical (TSE:4502) enters these announcements with a share price of ¥5,614.0 and multi year...

Mimaki Engineering (TSE:6638) has just posted its latest numbers, with Q2 2026 revenue at ¥19.97b and basic EPS of ¥49.50, alongside net income of ¥1,432m. The company has seen revenue move from ¥20.43b in Q3 2025 to ¥19.97b in Q2 2026, while quarterly basic EPS has ranged from ¥61.30 in Q2 2025 to ¥41.91 in Q4 2025 and then ¥49.50 in the most recent quarter, framing a results season where margins are very much in focus for investors. See our full analysis for Mimaki Engineering. With the...

Fukuda (TSE:1899) has put solid numbers on the table for FY 2025 so far, reporting third quarter revenue of ¥42,230 million and basic EPS of ¥229.11. These figures are supported by trailing 12 month revenue of about ¥169.7 billion and EPS of ¥702.19. The company has reported revenue ranging from ¥34,299 million in FY 2024 Q2 to ¥49,987 million in FY 2024 Q4. Over the same periods, basic EPS has moved from ¥69.74 to ¥229.11, giving investors a clearer view of how the top and bottom lines have...

Fujii Sangyo (TSE:9906) has put up another solid set of numbers, with Q2 2026 revenue of ¥26.8 billion and basic EPS of ¥170.78, while trailing twelve month revenue sits at ¥101.9 billion and EPS at ¥579.82, alongside net earnings growth of 35.3% over the last year. Over the past few quarters the company has seen revenue move from ¥24.7 billion and EPS of ¥81.58 in Q3 2025 to ¥26.8 billion and EPS of ¥170.78 in Q2 2026, against a backdrop of trailing net profit margin improving to 4.8% from...

Remixpoint (TSE:3825) has put up a busy run of results, with Q2 2026 revenue at ¥8.5b and basic EPS at ¥13.02. This comes against a backdrop where trailing 12 month EPS reached ¥24.33 on revenue of ¥24.9b and net income of ¥3.1b. Over the past few reported quarters, the company has seen revenue move from ¥4.3b and EPS of ¥0.16 in Q1 2025 to ¥6.5b and EPS of ¥18.13 in Q1 2026. This was alongside swings that included a Q4 2025 EPS loss of ¥16.02 on revenue of ¥4.3b. With net profit margin for...

Pro-Ship (TSE:3763) has reported another solid set of numbers for Q3 2026, with recent quarterly revenue ranging from ¥1,485 million to ¥2,610 million and EPS moving between ¥6.61 and ¥41.76 per share over the past six reported quarters. Trailing twelve month EPS reached ¥100.72 on revenue of ¥8.34 billion. Over the same twelve month window, earnings increased 69.4% and net profit margin rose from 21.4% to 30%. This latest update highlights a clear profitability angle that investors are...

Kyosan Electric Manufacturing (TSE:6742) has just posted its Q3 2026 scorecard, with recent quarterly revenue figures ranging from ¥9.8b to ¥39.1b and EPS swinging between a loss of ¥17.79 and a profit of ¥71.85 over the last six reported quarters. Trailing twelve month EPS has moved from ¥56.87 to ¥81.12 as revenue has tracked between ¥72.8b and ¥90.9b. Investors are now weighing those shifting top line and EPS trends against a 33.7% earnings increase over the past year and a net margin that...

Sec Carbon Limited (TSE:5304) has put fresh numbers on the table for Q3 2026, with Q2 revenue at ¥5,921 million and basic EPS of ¥47.99, set against a trailing 12 month net profit margin of 15.2% compared with 19% a year earlier. Over recent quarters, revenue has moved from ¥7,984 million in Q2 2025 and ¥7,359 million in Q3 2025 to ¥4,378 million in Q1 2026 and ¥5,921 million in Q2 2026. Basic EPS shifted from ¥63.78 and ¥85.45 in those 2025 quarters to ¥33.52 and ¥47.99 in 2026, giving...

Iwaki (TSE:6237) has just posted its Q3 2026 numbers, with recent quarterly revenue sitting around ¥11.4b and Basic EPS of about ¥58, alongside trailing twelve month EPS of roughly ¥208 and net income of about ¥4.6b. This positions the update within a steady earnings profile. Over the past few reported periods, revenue has hovered in the ¥11.2b to ¥11.7b range per quarter while Basic EPS moved between roughly ¥33 and ¥71. This gives investors a clearer view of how profits track against a...

Zenitaka (TSE:1811) has put fresh Q3 2026 numbers on the table, with recent quarterly revenue running at about ¥31.1 billion and basic EPS of ¥61.45, set against a trailing twelve month EPS of ¥572.27 that reflects a 231.8% earnings lift over the past year. The company has seen revenue move from ¥26.1 billion in Q2 2025 to ¥31.1 billion in Q2 2026. Over the same period, basic EPS shifted from ¥149.30 to ¥61.45, giving investors a mixed first impression on the quarterly run rate even as...

MEC (TSE:4971) has reported its FY 2025 results with third quarter revenue of ¥5.6b and basic EPS of ¥78.42, set against trailing twelve month revenue of ¥19.5b and EPS of ¥160.99. The company has seen revenue move from ¥4.55b in FY 2024 Q4 to ¥5.6b in FY 2025 Q3, while quarterly basic EPS shifted from a loss of ¥17.97 in FY 2024 Q4 to ¥78.42 in FY 2025 Q3 and trailing twelve month EPS moved from ¥122.35 in FY 2024 Q4 to ¥160.99 in FY 2025 Q3. With a trailing net margin of 15.3% versus 18.2%...

Obara Group (TSE:6877) has opened Q1 2026 reporting season against a backdrop of steady top line and earnings, coming off Q4 2025 revenue of ¥16.5b and basic EPS of ¥115.33, alongside trailing 12 month EPS of ¥424.88 on revenue of ¥61.7b. Over recent quarters the company has seen revenue move from ¥15.0b in Q2 2025 to ¥16.5b in Q4 2025, while basic EPS shifted from ¥91.16 to ¥127.78 and then to ¥115.33. This gives investors a clear view of how profitability has tracked alongside sales. With a...